Life Sciences

The pharma supply chain faces unique challenges as it adapts to a new global model.

Nearshoring efforts and climate impacts regularly disrupting supply chains are just two of the challenges facing the life sciences supply chain, and lives are at stake if it fails.

Prior to the COVID-19 pandemic, due in part to the growing demand for ecommerce, the supply chain was already experiencing a shortage of readily available labor.

In this industry perspective paper, we detail how, even though supply chain events such as the COVID-19 pandemic are impossible to predict, life sciences organizations can at least, be prepared by taking an intentional approach to risk management, response, and continuous supply chain design.

While there have been some positive developments, in recent days regarding new vaccines for the ongoing COVID-19 pandemic, a white paper issued today sponsored by North Reading, Mass.-based TraceLink, a provider of supply chain visibility platform services for the life sciences supply chain, in collaboration with research firm IDC, highlighted the myriad challenges that the pandemic has wrought upon pharmaceutical shippers.